Pamela Tranter

Head Translational Research Group, UCL Translational Research Office • UCL

Pamela joined UCL Translational Research Office (TRO) in 2014 and has been leading the Translational Research group since 2016.    The TRO collaborates with academics, industry partners and external funding bodies, to facilitate the translation of UCL’s emerging research into therapies and medical products.   Pamela is the project manager for substantial late pre-clinical/early clinical advanced therapy projects, with a particular emphasis on CAR T cells and  Rare diseases. The TRO has supported more than 100 active projects with a value of greater than £150 Million. 

 Pamela is leading a key initiative to develop Therapeutic Innovation Networks (TINs) for all therapeutic modalities across UCL, which is supported by a WT Translational Partnership Award.  

 Prior to joining UCL, Pamela gained extensive experience of drug discovery in the pharmaceutical industry at Novartis/Ciba-Geigy where she led small molecule and biologics projects for respiratory and thrombosis indications.  


Also speaking

Michael Leek

Executive Chairman & Founder • TC Biopharm

Ann-Hunter Van Kirk

Senior Equity Research Analyst Biopharmaceuticals • Bloomberg Intelligence

Anthony Davies

Founder & CEO • Dark Horse Consulting

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.